DTaP-IPV-HB-PRP~T vaccine

BIOLOGICAL3 trials

Sponsors

Sanofi Pasteur, a Sanofi Company

Conditions

DiphtheriaHepatitis BPertussisPolioPoliomyelitisTetanus

Phase 3

Immunogenicity of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® at 2-3-4 Months Schedule

CompletedNCT00315055

Sanofi Pasteur, a Sanofi CompanyDiphtheria, Hepatitis B, Pertussis +1

Start: 2006-07-31End: 2008-02-29Updated: 2014-09-12

Lot Consistency Study of DTaP-IPV-HB-PRP~T Vaccine Administered at 2-4-6 Months of Age in Healthy Infants

CompletedNCT00404651

Sanofi Pasteur, a Sanofi CompanyDiphtheria, Hepatitis B, Pertussis +2

Start: 2006-11-30End: 2008-07-31Updated: 2014-05-09

Study of Immunogenicity and Safety of a Booster Dose of DTaP-IPV-HB-PRP~T Combined Vaccine in Healthy Turkish Infants

CompletedNCT00619502

Sanofi Pasteur, a Sanofi CompanyDiphtheria, Hepatitis B, Pertussis +1

Start: 2007-12-31End: 2008-07-31Updated: 2016-05-13